These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1901042

  • 1. Serum prolactin levels in patients treated with a gonadotropin-releasing hormone analogue for adenocarcinoma of the prostate.
    Siegel YI, Korczak D, Lindner A.
    Eur Urol; 1991; 19(1):16-8. PubMed ID: 1901042
    [Abstract] [Full Text] [Related]

  • 2. Endocrine studies with a gonadotropin-releasing hormone analogue to achieve withdrawal of testosterone in prostate carcinoma patients.
    Wenderoth UK, Happ J, Krause U, Adenauer H, Jacobi GH.
    Eur Urol; 1982; 8(6):343-7. PubMed ID: 6814918
    [Abstract] [Full Text] [Related]

  • 3. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
    Banchini A, Zavaroni D, Tarditi E, Cortellini P, Ziveri M, Polotti R, Stefani F, Valenti G.
    Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
    [Abstract] [Full Text] [Related]

  • 4. Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
    Ahmann FR, Citrin DL, deHaan HA, Guinan P, Jordan VC, Kreis W, Scott M, Trump DL.
    J Clin Oncol; 1987 Jun; 5(6):912-7. PubMed ID: 2953870
    [Abstract] [Full Text] [Related]

  • 5. The role of increased prolactin levels under GnRH analogue treatment in advanced prostatic carcinoma.
    Matzkin H, Kaver I, Lewyshon O, Ayalon D, Braf Z.
    Cancer; 1988 Jun 01; 61(11):2187-91. PubMed ID: 3130176
    [Abstract] [Full Text] [Related]

  • 6. Prolactin and pituitary gonadotropin values and responses to acute luteinizing hormone-releasing hormone (LHRH) challenge in patients having long-term treatment with a depot LHRH analogue.
    Mahler C, Verhelst J, Chaban M, Denis L.
    Cancer; 1991 Feb 01; 67(3):557-9. PubMed ID: 1824680
    [Abstract] [Full Text] [Related]

  • 7. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue.
    Huhtaniemi I, Nikula H, Rannikko S.
    J Clin Endocrinol Metab; 1985 Oct 01; 61(4):698-704. PubMed ID: 2993345
    [Abstract] [Full Text] [Related]

  • 8. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
    Waxman JH, Wass JA, Hendry WF, Whitfield HN, Besser GM, Malpas JS, Oliver RT.
    Br Med J (Clin Res Ed); 1983 Apr 23; 286(6374):1309-12. PubMed ID: 6404441
    [Abstract] [Full Text] [Related]

  • 9. Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.
    Presant CA, Soloway MS, Klioze SS, Yakabow A, Presant SN, Mendez RG, Kennedy PS, Wyres MR, Naessig VL, Todd B.
    Cancer; 1987 May 15; 59(10):1713-6. PubMed ID: 3103904
    [Abstract] [Full Text] [Related]

  • 10. Kinetic evaluation of the effect of LHRH analog on prostatic cancer using transrectal ultrasonotomography.
    Kojima M, Watanabe H, Ohe H, Miyashita H, Inaba T.
    Prostate; 1987 May 15; 10(1):11-7. PubMed ID: 3103113
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone.
    Waxman JH, Wass JA, Hendry WF, Whitfield HN, Bary P, Besser GM, Malpas JS, Oliver RT.
    Br J Urol; 1983 Dec 15; 55(6):737-42. PubMed ID: 6418264
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone agonistic analogues in the treatment of advanced prostatic carcinoma.
    Koutsilieris M, Tolis G.
    Prostate; 1983 Dec 15; 4(6):569-77. PubMed ID: 6415629
    [Abstract] [Full Text] [Related]

  • 13. Clinical importance of prostatic measurements in follow-up of GnRH analogue-treated prostatic carcinoma patients.
    Matzkin H, Greenstein A, Braf Z.
    Urology; 1990 Sep 15; 36(3):214-8. PubMed ID: 2118285
    [Abstract] [Full Text] [Related]

  • 14. Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment.
    Wenderoth UK, Jacobi GH.
    Prog Clin Biol Res; 1985 Sep 15; 185A():297-305. PubMed ID: 3162176
    [Abstract] [Full Text] [Related]

  • 15. The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostate.
    Trachtenberg J.
    J Urol; 1982 Nov 15; 128(5):1097-100. PubMed ID: 6294350
    [Abstract] [Full Text] [Related]

  • 16. [Testicular endocrine function in patients with prostatic cancer receiving medical castration by long-term administration of LH-RH agonists].
    Isurugi K, Kondo Y, Hirasawa K, Oyamatsu T, Honma Y.
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct 15; 80(10):1466-73. PubMed ID: 2513445
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].
    Wenderoth UK, Jacobi GH.
    Ann Urol (Paris); 1986 Oct 15; 20(2):95-7. PubMed ID: 3087269
    [Abstract] [Full Text] [Related]

  • 18. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP.
    J Pharmacol; 1983 Oct 15; 14 Suppl 3():117-35. PubMed ID: 6423907
    [Abstract] [Full Text] [Related]

  • 19. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy.
    Huhtaniemi IT, Dahl KD, Rannikko S, Hsueh AJ.
    J Clin Endocrinol Metab; 1988 Feb 15; 66(2):308-13. PubMed ID: 3123510
    [Abstract] [Full Text] [Related]

  • 20. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
    Kuhn JM, Billebaud T, Navratil H, Moulonguet A, Fiet J, Grise P, Louis JF, Costa P, Husson JM, Dahan R.
    N Engl J Med; 1989 Aug 17; 321(7):413-8. PubMed ID: 2503723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.